- Home
- SPNT vs TVTX Comparison
SPNT vs TVTX Comparison
Compare SPNT & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPNT | TVTX |
|---|---|---|
| Founded | 2011 | N/A |
| Country | Bermuda | United States |
| Employees | 1099 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | SPNT | TVTX |
|---|---|---|
| Price | $23.38 | $40.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $27.50 | ★ $40.62 |
| AVG Volume (30 Days) | 668.7K | ★ 2.4M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 92.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.85 | $44.76 |
| Revenue Next Year | $5.85 | $35.51 |
| P/E Ratio | $5.65 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.54 | $13.88 |
| 52 Week High | $23.97 | $43.31 |
Technical Indicators
Market Signals| Indicator | SPNT | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 60.00 | 63.32 |
| Support Level | $19.56 | $32.62 |
| Resistance Level | $23.42 | $42.06 |
| Average True Range (ATR) | 0.54 | 2.03 |
| MACD | -0.01 | 0.16 |
| Stochastic Oscillator | 66.85 | 78.40 |
Price Performance
Historical ComparisonAbout SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.